Apellis Pharmaceuticals, Inc. (APLS) Earnings
|
Expand Research on APLS
| Next EPS Date | 7/31/26 *Est. | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +36.3% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -6.1% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/11/26  |
Q126 | N/A | -$0.34 | N/A | N/A | $203.58M | N/A | N/A | N/A | ||
| 5/7/26 |
Q126 | N/A | -$0.34 | N/A | N/A | $203.58M | N/A | N/A | N/A | ||
| 5/5/26 |
Q126 | N/A | -$0.34 | N/A | N/A | $203.58M | N/A | N/A | N/A | ||
| 5/4/26 |
Q126 | N/A | -$0.34 | N/A | N/A | $203.58M | N/A | N/A | N/A | ||
| 5/1/26 |
Q126 | N/A | -$0.34 | N/A | N/A | $203.58M | N/A | N/A | N/A | ||
| 4/30/26 |
Q126 | N/A | -$0.34 | N/A | N/A | $203.58M | N/A | N/A | N/A | ||
| 2/24/26 | Q425 | $0.47 | -$0.38 | +$0.85 | $199.91M | $198.82M | N/A |  | | Details | |
| 10/30/25 | Q325 | $1.67 | $1.55 | +$0.12 | $458.6M | $450.97M | N/A | | | Details |
